{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"abetal34v-amyloidosis","columns":[{"gene":"","key":"population-c316ea9d47686e99f9e2","label":"ABetaL34V amyloidosis","mondoId":"MONDO:0017945","onsetQualifier":null,"originColumnKey":"MONDO:0017945/ORPHA:324703","originalViews":[{"key":"MONDO:0017945/ORPHA:324703","label":"ABetaL34V amyloidosis","scopeLabel":"ORPHA:324703","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["36d4019a99be78f4e9d7da4a7678d46bfae1ee474009acaddedb6a5b7c5bbd59","61738785d8b1d2ffb9d7fce1a311c2b81e6b622af59691ce389129f79da528fb","697f2ee2a2ee24d95102a609a081270bdee3a30e4c8276061c8ead8cfe2f483c","b422f435f1d8ad53a2a874424a67658fb57883010181308d8098256662eb6d2f","c5f3d587457cf8f8ca6dde032a76e9756f0e66c0df9fa90940dc023d40e9cd00","c63892ad5e549c67fcc1bbe29a06265af48b2df99c9895f182c3f52e9e28a024","d074b691a70a2651244cd022e4f443c1d0bf724227169c98392e6701a36fa073","d4b7d656ad0469612211c1dd234f92b630eac3973fd6609c79d5cf1a7337f4c2","e45da6de5738f96a2b994ac9078f3da7235b5e9473866d3c737f95e6a78a8f7d","e9d29a943856be036ae6b89cf6358f0bfb30f63f594b88cae3280ff4353fc106","fcddd02dd95665d11a65e9aa1b0d75ec7f1d7f4fb0d0b2e0c7281110a7baea6d"],"recordQualifiers":{},"scopeLabel":"ORPHA:324703","sourceIds":["ORPHA:324703"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-c316ea9d47686e99f9e2"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0100659","HP:0000708","HP:0001342","HP:0001259","HP:0000726","HP:0001263","HP:0001249"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":11,"sourceGroups":{"orphanet":11}},"features":[{"hpoId":"HP:0100659","label":"Abnormal cerebral vascular morphology","primary":true},{"hpoId":"HP:0000708","label":"Atypical behavior","primary":true},{"hpoId":"HP:0001342","label":"Cerebral hemorrhage","primary":true},{"hpoId":"HP:0001259","label":"Coma","primary":true},{"hpoId":"HP:0000726","label":"Dementia","primary":true},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":true},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":true},{"hpoId":"HP:0002076","label":"Migraine","primary":false},{"hpoId":"HP:0003401","label":"Paresthesia","primary":false},{"hpoId":"HP:0003474","label":"Somatic sensory dysfunction","primary":false},{"hpoId":"HP:0001297","label":"Stroke","primary":false}],"ledeHtml":"Hereditary cerebral hemorrhage with amyloidosis (HCHWA), Piedmont type is a form of HCHWA characterized by an age of onset between 50-70 years of age, recurrent lobar intracerebral hemorrhages and cognitive decline.","mondoId":"MONDO:0017945","node":{"canonicalSlug":"abetal34v-amyloidosis","comparisons":[{"documentSha256":"a21abfd00c9b03cf5c1837dfa135204c8193380463003c0259450e97e4f4fa3d","key":"legacy-cerebral-amyloid-angiopathy","kind":"legacy","label":"cerebral amyloid angiopathy","memberIds":["MONDO:0005620","MONDO:0007098","MONDO:0011583","MONDO:0015033","MONDO:0017945","MONDO:0017946","MONDO:0017947","MONDO:0017949"],"mondoId":"MONDO:0005620","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/cerebral-amyloid-angiopathy.a21abfd00c9b03cf5c1837dfa135204c8193380463003c0259450e97e4f4fa3d.json"},{"documentSha256":"4748dda3b4e7321cf829138b3671ad88cffd3ea01a5ff26d552cc9a4570b8da4","key":"expanded-cerebral-amyloid-angiopathy","kind":"expanded","label":"cerebral amyloid angiopathy","memberIds":["MONDO:0005620","MONDO:0007098","MONDO:0007297","MONDO:0008306","MONDO:0011583","MONDO:0015033","MONDO:0017945","MONDO:0017946","MONDO:0017947","MONDO:0017948","MONDO:0017949"],"mondoId":"MONDO:0005620","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-4748dda3b4e7321cf829.4748dda3b4e7321cf829138b3671ad88cffd3ea01a5ff26d552cc9a4570b8da4.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"ABetaL34V amyloidosis","paragraphs":["Hereditary cerebral hemorrhage with amyloidosis (HCHWA), Piedmont type is a form of HCHWA characterized by an age of onset between 50-70 years of age, recurrent lobar intracerebral hemorrhages and cognitive decline."],"scope":"exact","source":"MONDO","upstream":"Orphanet:324703","url":"https://monarchinitiative.org/MONDO:0017945"},"ownColumnKeys":["population-c316ea9d47686e99f9e2"],"publication":"published","relationships":[{"kind":"parent","label":"cerebral amyloid angiopathy, APP-related","mondoId":"MONDO:0011583","slug":"cerebral-amyloid-angiopathy-app-related"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/17489"}],"translation":"published"},"records":[{"frequencyKind":"range","key":"36d4019a99be78f4e9d7da4a7678d46bfae1ee474009acaddedb6a5b7c5bbd59","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324703","disease_name":"ABetaL34V amyloidosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000708","is_excluded":false,"label":"Atypical behavior","onset_id":null,"reference":"ORPHA:324703","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"61738785d8b1d2ffb9d7fce1a311c2b81e6b622af59691ce389129f79da528fb","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324703","disease_name":"ABetaL34V amyloidosis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001259","is_excluded":false,"label":"Coma","onset_id":null,"reference":"ORPHA:324703","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"697f2ee2a2ee24d95102a609a081270bdee3a30e4c8276061c8ead8cfe2f483c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324703","disease_name":"ABetaL34V amyloidosis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"ORPHA:324703","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b422f435f1d8ad53a2a874424a67658fb57883010181308d8098256662eb6d2f","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:324703","disease_name":"ABetaL34V amyloidosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100659","is_excluded":false,"label":"Abnormal cerebral vascular morphology","onset_id":null,"reference":"ORPHA:324703","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c5f3d587457cf8f8ca6dde032a76e9756f0e66c0df9fa90940dc023d40e9cd00","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:324703","disease_name":"ABetaL34V amyloidosis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001297","is_excluded":false,"label":"Stroke","onset_id":null,"reference":"ORPHA:324703","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c63892ad5e549c67fcc1bbe29a06265af48b2df99c9895f182c3f52e9e28a024","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:324703","disease_name":"ABetaL34V amyloidosis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001342","is_excluded":false,"label":"Cerebral hemorrhage","onset_id":null,"reference":"ORPHA:324703","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d074b691a70a2651244cd022e4f443c1d0bf724227169c98392e6701a36fa073","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324703","disease_name":"ABetaL34V amyloidosis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003401","is_excluded":false,"label":"Paresthesia","onset_id":null,"reference":"ORPHA:324703","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d4b7d656ad0469612211c1dd234f92b630eac3973fd6609c79d5cf1a7337f4c2","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324703","disease_name":"ABetaL34V amyloidosis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000726","is_excluded":false,"label":"Dementia","onset_id":null,"reference":"ORPHA:324703","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e45da6de5738f96a2b994ac9078f3da7235b5e9473866d3c737f95e6a78a8f7d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324703","disease_name":"ABetaL34V amyloidosis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003474","is_excluded":false,"label":"Somatic sensory dysfunction","onset_id":null,"reference":"ORPHA:324703","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e9d29a943856be036ae6b89cf6358f0bfb30f63f594b88cae3280ff4353fc106","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324703","disease_name":"ABetaL34V amyloidosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002076","is_excluded":false,"label":"Migraine","onset_id":null,"reference":"ORPHA:324703","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fcddd02dd95665d11a65e9aa1b0d75ec7f1d7f4fb0d0b2e0c7281110a7baea6d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324703","disease_name":"ABetaL34V amyloidosis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"ORPHA:324703","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0017945\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:324703</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Hereditary cerebral hemorrhage with amyloidosis (HCHWA), Piedmont type is a form of HCHWA characterized by an age of onset between 50-70 years of age, recurrent lobar intracerebral hemorrhages and cognitive decline.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0017945\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"abetal34v-amyloidosis","sourceDocuments":[{"name":"MONDO: ABetaL34V amyloidosis","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0017945"}],"sourceNote":"","synonyms":["ABeta amyloidosis, Piedmont type","ABetaL34V-related amyloidosis","HCHWA, Piedmont type","hereditary cerebral haemorrhage with amyloidosis, Piedmont type","hereditary cerebral hemorrhage with amyloidosis, Piedmont type"],"takeawayHtml":"","title":"ABetaL34V amyloidosis"},"schemaVersion":1}
